Conference Coverage

Chelation plus vitamins halved cardiovascular events in diabetics


 

AT THE AHA SCIENTIFIC SESSIONS

In addition, in diabetic patients the formation of advanced glycation endpoints requires catalytic activity by metals in order to create oxygen species and cross linkage, he continued.

The TACT trial was sponsored by the National Center for Complementary and Alternative Medicine and the National Heart, Lung, and Blood Institute. Dr. Lamas reported having no relevant financial interests.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Statin use linked to lower cataract risk
MDedge Internal Medicine
‘Substantial’ weight loss seen 3 years after bariatric surgery
MDedge Internal Medicine
CVD more prevalent in chronic kidney disease patients
MDedge Internal Medicine
FDA moves to reduce or remove unhealthy trans fats from foods
MDedge Internal Medicine
ACC-AHA cardiovascular prevention guidelines drop cholesterol treatment goals
MDedge Internal Medicine
Intervention boosts post-acute coronary syndrome medication adherence, but not outcomes
MDedge Internal Medicine
Abandon LDL targets? Not yet
MDedge Internal Medicine
Guideline authors, AHA-ACC leaders confident in risk calculator
MDedge Internal Medicine
Noninvasive coronary test accurate for lesion-specific ischemia
MDedge Internal Medicine
FDA lifts rosiglitazone prescribing restrictions
MDedge Internal Medicine